Position in BMY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,372,220
-$81,257 QoQ
Shares Held
23,815
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#994
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONARCH CAPITAL MANAGEMENT INC holds $54,521,424 across 10 Drug Manufacturers - General names. BMY ranks #6 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
119,322 | $15,332,877 | |
| 2 | JNJ |
Johnson & Johnson
|
57,752 | $14,667,275 | |
| 3 | ABBV |
AbbVie Inc.
|
49,047 | $12,342,187 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
40,685 | $5,140,142 | |
| 5 | PFE |
Pfizer Inc
|
127,572 | $3,071,933 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
23,815 | $1,372,220 | |
| 7 | LLY |
ELI LILLY & Co
|
1,108 | $1,328,968 | |
| 8 | NVO |
Novo Nordisk A S
|
16,150 | $774,231 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,372,220 | 23,815 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,453,477 | 23,965 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $1,293,481 | 23,980 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,081,498 | 23,980 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,132,021 | 24,455 | Shares | Sole | 2025-08-20 | |
| 2025-03-31 | $1,488,643 | 24,408 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,380,516 | 24,408 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,265,456 | 24,458 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $1,006,188 | 24,228 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $1,360,739 | 25,092 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $1,287,573 | 25,094 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $1,469,514 | 25,319 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $1,619,150 | 25,319 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $1,754,859 | 25,319 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $1,821,702 | 25,319 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $1,799,927 | 25,319 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $1,956,955 | 25,415 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $1,858,467 | 25,448 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $1,586,682 | 25,448 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $1,505,758 | 25,448 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $1,700,435 | 25,448 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $1,608,994 | 25,487 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $1,580,958 | 25,487 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $1,543,303 | 25,598 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $1,511,042 | 25,698 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $1,495,392 | 26,828 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||